NJ S1792Introducedas of 2026-01-13
Establishes program to subsidize purchase price of medical cannabis for registered qualifying patients enrolled in Medicaid or NJ FamilyCare programs.
Plain-English summary
What happened: A New Jersey bill to establish a program subsidizing medical cannabis purchase prices for Medicaid and NJ FamilyCare enrollees, introduced in the Senate and referred to committee.
Why it matters: A subsidy program could increase patient access to medical cannabis and affect sales volumes at licensed dispensaries serving low-income patients.
Affects: retailers and patients
LATEST ACTION: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
READ THE FULL BILL TEXT →Follow New Jersey cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digestMore New Jersey cannabis bills
S4635Aligns State restrictions on sale of hemp products and intoxicating hemp beverages with federal law.Passed ChamberA5649Prohibits law enforcement officers, first responders, CDL drivers, or persons who operate heavy equipment from engaging in recreational use of cannabis items.IntroducedA5683Allows Cannabis Regulatory Commission to award competitive grants from Social Equity Excise Fee proceeds.IntroducedS4726Allows Cannabis Regulatory Commission to award competitive grants from Social Equity Excise Fee proceeds.IntroducedA5604Aligns State restrictions on sale of hemp products and intoxicating hemp beverages with federal law.IntroducedS4685Prohibits law enforcement officers, first responders, CDL drivers, or persons who operate heavy equipment from engaging in recreational use of cannabis items.IntroducedA5463Requires cannabis retailer to display notice of risks of high potency cannabis.IntroducedA5476Requires training for employees in certain settings to recognize and respond to indications of intoxication in children from consumption of cannabis item.Introduced
ALL NEW JERSEYCANNABIS LAWS & BILLS →Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.